Biofil Chemicals & Pharmaceuticals share news, announcements and annual reports
NSE: BIOFILCHEMBSE: 524396Pharmaceuticals & BiotechnologySmall Cap
Biofil Chemicals & Pharmaceuticals Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1994 on BSE, Jun 1996 on NSE
Last close ₹28.68down ₹0.73 (2.48%)BSE ₹29.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹29.41.
30 Oct: open ₹29.00, high ₹29.80, low ₹28.26
52-week range of traded prices to 30 Oct 2026
₹25.60Low, 30 Mar 2026₹46.34High, 3 Feb 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹47 Cr3,363rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 96.41
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.16
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 2.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 2.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.14
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,71974.4% delivered
Biofil Chemicals & Pharmaceuticals board meetings
116 filed, newest first. Page 2 of 3.
Feb 2020
14 Feb · Board meeting
4 Feb · Board meeting
Nov 2019
Aug 2019
13 Aug · Board meeting
May 2019
30 May · Board meeting
22 May · Board meeting
Feb 2019
13 Feb · Board meeting
4 Feb · Board meeting
Nov 2018
Aug 2018
13 Aug · Board meeting
13 Aug · Board meeting
13 Aug · Board meeting
6 Aug · Board meeting
May 2018
30 May · Board meeting
23 May · Board meeting
Feb 2018
12 Feb · Board meeting
Nov 2017
Aug 2017
4 Aug · Board meeting
Jul 2017
May 2017
Feb 2017
Jan 2017
Nov 2016
Aug 2016
10 Aug · Board meeting
May 2016
Feb 2016
13 Feb · Board meeting
Oct 2015
Aug 2015
13 Aug · Board meeting
May 2015
Feb 2015
3 Feb · Board meeting
To take on record and approve the following matters : 1. Un-audited Financial Results of the Company for the quarter ended on December 31, 2014.
Nov 2014
4 Nov · Board meeting
To take on record and approve the following matters : 1.Un-audited Financial Results of the Company for the quarter ended September 30, 2014.
Aug 2014
4 Aug · Board meeting
To take on record and approve the following matters: 1.Un-audited Financial Results of the Company for the quarter ended June 30, 2014. 2. To consider and fix the Notice of Annual General Meeting and Book closure date for the financial year ended March 31, 2014. 3. To fix the cut-off date to record the entitlement of the shareholders to cast their vote electronically at the ensuing AGM by electronic means under the Companies Act, 2013 and rules made there under. Further, in terms of provisions of the Company's Code of Conduct for Prevention of Insider Trading (Code) the "Trading Window" for trading in equity shares of the Company shall remain closed from August 4, 2014 to August 15, 2014 for all the Designated employees and Directors of the Company for the purpose approval quarterly financial statement for the quarter ended June 30, 2014.
May 2014
20 May · Board meeting
To transact the following matters along with other routine matters: 1) To consider and approve the Audited Financial Results for the Quarter as well as year ended March 31, 2014. 2) Any other matter with the permission of the chair. Further, in terms of provisions of the Company's Code of Conduct for Prevention of Insider Trading (Code), the "Trading Window" for trading in the equity shares of the Company shall remain closed from May 16, 2014 to June 02, 2014, for all the designated employees and Directors of the Company for the purpose approval quarterly as well Annual financial statement.
Feb 2014
4 Feb · Board meeting
To take on record the Un-audited Financial Results of the Company for the quarter ended on December 31, 2013 along with other routine business.
Nov 2013
11 Nov · Board meeting
To take on record and approve the Un-audited Financial Results of the Company for the quarter ended on September 30, 2013 along with other routine business.
Aug 2013
7 Aug · Board meeting
To take on record and approve the Un-audited Financial Results of the Company for the quarter ended on June 30, 2013 along with other routine business.
Nov 2012
2 Nov · Board meeting
To take on record and approve the Un-audited Financial Results of the Company for the quarter ended on September 30, 2012 along with other routine business.
May 2012
18 May · Board meeting
To consider and approve the Audited Financial Result for the Quarter as well as year ended March 31, 2012 along with other routine business.
Feb 2012
1 Feb · Board meeting
To take on record the Un-audited Financial Results of the Company for the quarter ended on December 31, 2011 along with other routine business.
Nov 2011
3 Nov · Board meeting
To take on record the Un-audited Financial Results of the Company for the quarter ended on September 30, 2011 alongwith other routine business.
Jul 2011
25 Jul · Board meeting
To take on record the Un-audited Financial Results of the Company for the quarter ended on June 30, 2011 alongwith other routine business.
May 2011
24 May · Board meeting
To consider and approve the Audited Financial Result for the Quarter as well as year ended March 31, 2011 along with other routine business.
Mar 2011
29 Mar · Board meeting
Members of the Company have accorded their permission on March 23, 2011 to re-issue of 57,12,500 forfeited equity shares at the price of Rs. 7/- each. For this purpose a meeting of Board of Directors of the company is scheduled to be held on March 31, 2011 for allotment of the 5712500 forfeited equity shares.
Feb 2011
21 Feb · Board meeting
At the Board meeting held on February 21, 2011 the Board has passed resolution for re-issuance of forfeited 5712500 equity shares subject to confirmation of shareholders in ensuing Extra- Ordinary general Meeting of the company which is scheduled to be held on March 23, 2011.